Riskpilot← Back to searchSign inGet full accessCYPROMED AS
ASActiveOrg 974212153Vikavegen 17, 2312 OttestadManufacture of medical and dental instruments and supplies · NACE 3250Est. 199527 employees
Revenue 2024
NOK 47,3M
+15% vs 2023
EBITDA margin
14.7%
+3% vs 2023
Equity ratio
38.9%
Financial strength
Net profit 2024
NOK 4,8M
-2% vs 2023
| Revenue | NOK 47,3M | +15% |
| EBITDA | NOK 7M | +3% |
| Net profit | NOK 4,8M | -2% |
| Total assets | NOK 24,6M | -6% |
| Equity | NOK 9,5M | +9% |
| Employees | 27 | — |
Legal name
CYPROMED AS
Org number
974212153
Legal form
Aksjeselskap
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
2. januar 1995
Share capital
NOK 561 500
Employees
27 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Signatur hver for seg ragnar jan klevås knut-tomm kristensen
Address
Vikavegen 17, 2312 Ottestad
Phone
+4762574433
Email
service@cypromed.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 638 | 6 878 | 15 105 | 18 073 | 16 513 | 16 643 | 13 760 | 16 518 | 11 463 | 14 944 | 13 191 | 18 978 | 28 456 | 33 509 | 35 976 | 41 264 | 47 257 |
| Staff expenses | −1 750 | −1 773 | −2 565 | −3 166 | −3 963 | −3 908 | −3 950 | −4 846 | −2 851 | −4 274 | −5 285 | −7 158 | −9 245 | −11 307 | −13 383 | −13 499 | −16 346 |
| EBITDA | 1 238 | 1 356 | 4 291 | 5 663 | 3 261 | 3 398 | 1 780 | 2 774 | 1 253 | 3 735 | 118 | 1 282 | 6 012 | 6 771 | 6 237 | 6 736 | 6 956 |
| Depreciation & amort. | −0 | −57 | −81 | −1 083 | −90 | −107 | −179 | −105 | −103 | −81 | −77 | −154 | −133 | −206 | −311 | −310 | −768 |
| EBIT | 1 238 | 1 299 | 4 210 | 4 579 | 3 171 | 3 291 | 1 601 | 2 669 | 1 150 | 3 654 | 41 | 1 128 | 5 879 | 6 566 | 5 926 | 6 426 | 6 188 |
| Net financials | 83 | −37 | −482 | 49 | 65 | 59 | 109 | 63 | 109 | 27 | 55 | −14 | 15 | −4 | 3 | 47 | 123 |
| Profit before tax | 1 322 | 1 262 | 3 728 | 4 629 | 3 236 | 3 350 | 1 709 | 2 731 | 1 259 | 3 681 | 96 | 1 114 | 5 894 | 6 561 | 5 929 | 6 474 | 6 311 |
| Tax | 371 | 361 | 1 167 | 1 754 | 1 097 | 1 097 | 447 | 729 | 211 | 47 | −0 | 204 | 1 448 | 1 595 | 1 292 | 1 572 | 1 531 |
| Net profit | 951 | 901 | 2 561 | 2 875 | 2 139 | 2 252 | 1 263 | 2 002 | 1 048 | 3 634 | 96 | 910 | 4 446 | 4 966 | 4 636 | 4 902 | 4 780 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5 637 | 6 681 | 10 180 | 9 557 | 9 818 | 9 322 | 6 660 | 8 750 | 8 183 | 11 536 | 8 785 | 10 639 | 15 560 | 18 142 | 21 045 | 26 215 | 24 556 |
| Equity | 2 739 | 3 240 | 3 800 | 2 675 | 2 014 | 1 467 | 1 729 | 3 731 | 4 779 | 2 413 | 2 509 | 3 419 | 5 065 | 7 231 | 7 867 | 8 769 | 9 549 |
| Long-term debt | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 896 | 3 439 | 6 379 | 6 881 | 7 803 | 7 856 | 4 930 | 5 019 | 3 404 | 9 123 | 6 276 | 7 220 | 10 495 | 10 911 | 13 178 | 17 446 | 15 007 |
| Total debt | 2 898 | 3 441 | 6 379 | 6 881 | 7 803 | 7 856 | 4 930 | 5 019 | 3 404 | 9 123 | 6 276 | 7 220 | 10 495 | 10 911 | 13 178 | 17 446 | 15 007 |
EBITDA margin
14.7%
This company
15.8%
Market median
-7% vs market
20082024
Equity ratio
38.9%
This company
38.2%
Market median
+2% vs market
20082024
Return on equity
50.1%
This company
18.4%
Market median
+172% vs market
20082024
Net profit margin
10.1%
This company
8.1%
Market median
+25% vs market
20082024
Asset turnover
1.92×
This company
1.12×
Market median
+71% vs market
20082024
Debt / equity
1.57×
This company
0.62×
Market median
-153% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KK Deputy Member | Deputy Member | 2019 | — | — |
KS Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Doyle Holding As | Company | 75.2% | 75.2% | 2024 |
Belgravia Holding As | Company | 24.8% | 24.8% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Levanten As
CYPROMED AS Board members of CYPROMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristin Klevås Jahren | Deputy Member | 0 companies |
| Knut Schonhowd Kristensen | Chief Executive Officer | 0 companies |
| Ragnar Jan Klevaas | Chairman | 0 companies |
| Knut-Tomm Kristensen | Board of Directors | 0 companies |